The 6 analysts offering 12-month price forecasts for PDS Biotechnology Corp have a median target of 20.00, with a high estimate of 25.00 and a low estimate of 15.00. The median estimate represents a +67.79% increase from the last price of 11.92.
The current consensus among 6 polled investment analysts is to Buy stock in PDS Biotechnology Corp. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.21
Reporting Date Nov 10
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.